Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 4Phase 4 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Withdrawn 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 5Genitourinary 4Gastrointestinal 4Thoracic 3Sarcoma 3Lymphoid 3Gynecologic 3Plasma cell 2Other hematologic neoplasm 2NET 2Endocrine 2Head & Neck 1Breast 1

Conditions

Prostatic Neoplasms 1427Carcinoma, Renal Cell 587Urinary Bladder Neoplasms 368Kidney Neoplasms 257Carcinoma, Transitional Cell 190Neoplasm Metastasis 163Neoplasms 124Melanoma 83Breast Neoplasms 80Carcinoma, Non-Small-Cell Lung 78Testicular Neoplasms 67Ovarian Neoplasms 62Sarcoma 55Urethral Neoplasms 51Non-Muscle Invasive Bladder Neoplasms 51Wilms Tumor 49Lung Neoplasms 45Colorectal Neoplasms 44Uterine Cervical Neoplasms 39Neuroblastoma 39Penile Neoplasms 37Pancreatic Neoplasms 37Urologic Neoplasms 34Recurrence 32Lymphoma, Non-Hodgkin 32Ureteral Neoplasms 28Osteosarcoma 28Testicular Germ Cell Tumor 26Small Cell Lung Carcinoma 26Head and Neck Neoplasms 26

Interventions

grapiprant 1Radiosurgery 1Lycopene 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Disease Progression × Genitourinary × Clear all
NCT04974671 2025-12-04

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Yale University

Phase 2 Recruiting
30 enrolled
Genitourinary

Carcinoma, Renal Cell, Disease Progression

NCT04033432 2022-04-27

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Northwestern University

Phase 2 Unknown
14 enrolled 13 charts
Genitourinary

Prostatic Neoplasms, Disease Progression

NCT02538432 2019-11-04

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

University of Maryland, Baltimore

Phase 2 Withdrawn
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Disease Progression

NCT00172367 2008-09-26

Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma

National Taiwan University Hospital

Phase 2 Withdrawn
80 enrolled
Genitourinary

Carcinoma, Transitional Cell, Uremia, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡